全文获取类型
收费全文 | 15666篇 |
免费 | 1041篇 |
国内免费 | 77篇 |
专业分类
耳鼻咽喉 | 122篇 |
儿科学 | 322篇 |
妇产科学 | 325篇 |
基础医学 | 1905篇 |
口腔科学 | 347篇 |
临床医学 | 1526篇 |
内科学 | 3080篇 |
皮肤病学 | 194篇 |
神经病学 | 1565篇 |
特种医学 | 626篇 |
外科学 | 2394篇 |
综合类 | 183篇 |
现状与发展 | 1篇 |
一般理论 | 28篇 |
预防医学 | 1372篇 |
眼科学 | 520篇 |
药学 | 1196篇 |
中国医学 | 25篇 |
肿瘤学 | 1053篇 |
出版年
2024年 | 17篇 |
2023年 | 145篇 |
2022年 | 290篇 |
2021年 | 624篇 |
2020年 | 305篇 |
2019年 | 459篇 |
2018年 | 538篇 |
2017年 | 397篇 |
2016年 | 406篇 |
2015年 | 501篇 |
2014年 | 676篇 |
2013年 | 806篇 |
2012年 | 1302篇 |
2011年 | 1272篇 |
2010年 | 692篇 |
2009年 | 648篇 |
2008年 | 1008篇 |
2007年 | 1016篇 |
2006年 | 960篇 |
2005年 | 965篇 |
2004年 | 821篇 |
2003年 | 743篇 |
2002年 | 673篇 |
2001年 | 124篇 |
2000年 | 73篇 |
1999年 | 104篇 |
1998年 | 129篇 |
1997年 | 100篇 |
1996年 | 87篇 |
1995年 | 75篇 |
1994年 | 59篇 |
1993年 | 52篇 |
1992年 | 57篇 |
1991年 | 44篇 |
1990年 | 45篇 |
1989年 | 45篇 |
1988年 | 35篇 |
1987年 | 34篇 |
1986年 | 25篇 |
1985年 | 21篇 |
1984年 | 34篇 |
1983年 | 29篇 |
1982年 | 26篇 |
1981年 | 35篇 |
1980年 | 32篇 |
1978年 | 17篇 |
1977年 | 14篇 |
1976年 | 16篇 |
1975年 | 12篇 |
1974年 | 12篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
21.
Perinchery Narayan M.D. George Fournier M.D R. Indudhara M.D. R. Leidich M.D. K. Shinohara M.D. Alex Ingerman M.D. 《Urology》1994,43(6)
Objective. This prospective study was undertaken to evaluate the safety and efficacy of neodymium:yttrium-aluminium-garnet (Nd:YAG) laser for treatment of symptomatic benign prostatic hyperplasia (BPH).Methods. A total of 61 patients at a mean age of 71.6 years with symptomatic bladder outlet obstruction due to BPH underwent transurethral evaporation of prostate (TUEP) using Nd:YAG laser. Twelve of the patients were experiencing acute retention. Pre- and postoperative evaluation consisted of American Urological Association (AUA) symptom questionnaire and a sexual function questionnaire, uroflowmetry, postvoid residual urine, electrolytes, blood urea nitrogen, creatinine, hematocrit, and prostate volume estimation by transrectal ultrasound. TUEP was achieved by employing a side-firing Nd:YAG laser fiber with a durable quartz reflector and high-power density (Ultraline, Heraeus LaserSonics, Milpitas, CA) that was used in a contact mode.Results. All patients have been evaluated for three months, 26 for six rnonths, and 7 for twelve months. Mean prostatic size was 41.1 g. The mean improvement in symptom scores at one, three, six, and twelve months was 69.8 percent, 70.9 percent, 76.0 percent, and 70.9 percent, respectively (P = < 0.0001). The mean increase in maximum uroflow at one, three, six, and twelve months was 63.4 percent, 66.7 percent, 41.94 percent, and 164.52 percent, respectively (P = < 0.0001). There was no instance of significant fluid absorption or bleeding. The duration of postoperative catheterization was two days in 43 patients, three to seven days in 16 patients, and two to three weeks in 2 patients. There were no deaths. All patients evaluated by TRUS at six months had open channeling defects. Videocystoscopy performed in 16 patients at two to three months postoperatively revealed tissue slough. At repeat cystoscopy in these patients at six months, the prostatic fossa was completely healed with no evidence of tissue slough.Conclusions. It is concluded that the technique of TUEP using Nd:YAG laser is safe and, in preliminary results, appears apparently effective in the management of BPH. 相似文献
22.
Alex Y. Chang Z. Nora Tu Julia L. Smith Philip Bonomi Thomas J. Smith Peter H. Wiernik Ronald Blum 《Investigational new drugs》1995,13(2):137-141
Summary Fifty-five patients with metastatic non-small cell lung cancer (NSCLC) were entered into this phase II randomized study for evaluating three new agents: gallium nitrate, amonafide and teniposide. The patients had to have ECOG performance status 0 or 1, no prior chemotherapy, and adequate hematological, hepatic and renal functions. Forty-seven patients were eligible and evaluable. Fourteen were randomized to receive gallium nitrate, 18 to amonafide and 15 to teniposide. Seventy-four percent of eligible patients were male. The majority of patients (89%) had an ECOG performance status 1. ECOG grade 4 toxicity occurred twice in patients on gallium nitrate, seven times on amonafide and 18 times on teniposide. The cause of death was attributed to amonafide in one patient (from sepsis) and to teniposide in two patients (due to infection and leukopenia). There was no objective response in all the patients entered. The overall survival times ranged from 2 weeks to 156 weeks with a median of 23 weeks. There were no survival differences among the three treatment arms. We conclude that gallium nitrate, amonafide and teniposide are inactive in metastatic NSCLC and do not warrant any further testing in this disease.The contents of this study is solely the responsibility of the authors and does not necessarily represent the official views of the National Cancer Institute. 相似文献
23.
Alex Iranzo Esteban Mu?oz Joan Santamaria Isabel Vilaseca Montserrat Milà Eduardo Tolosa 《Movement disorders》2003,18(10):1179-1183
We evaluated the occurrence of REM sleep behaviour disorder (RBD) and vocal cord abductor paralysis (VCAP) in a group of 9 Machado-Joseph disease (MJD) patients. RBD was diagnosed by clinical history plus audiovisual polysomnography in 4 men and 1 woman (55%). While dreaming, 4 fell out of the bed and the other injured his arms. Laryngoscopy detected bilateral VCAP in 1 patient with stridor who required emergency tracheotomy, and partial vocal cord abductor restriction in 2. RBD and VCAP are two potentially injurious conditions that should be considered part of the clinical spectrum of MJD. 相似文献
24.
25.
26.
George Triadafilopoulos M.D. F.A.C.G. Alex Asian M.D. 《The American journal of gastroenterology》1991,86(8):952-955
Performance of same-day upper and lower endoscopy has many potential advantages, as it may reduce costs, shorten hospital stay, and expedite patient care, but its feasibility, efficacy, and potential have not been carefully defined. We report here our experience with a group of 87 patients who underwent same-day upper and lower endoscopy (174 procedures) over a 2-yr period at a tertiary care VA Hospital, compared with an alternate-day upper and lower endoscopy group of 50 patients (100 procedures) over the same time period. Most patients were elderly males. Common indications for endoscopy were occult or overt gastrointestinal bleeding, previous or concomitant history of pertinent pathology (i.e., polyps, ulcers), abdominal pain, diarrhea, or other symptoms, abnormal radiological studies, and iron deficiency anemia. Both groups required similar amounts of intravenous sedation. There were no complications in either group. In both groups, common positive findings were inflammation (i.e., colitis, esophagitis), benign neoplasms, diverticulae, peptic ulcer, and cancer. In both groups, only 2-6% had negative upper and lower endoscopy, whereas either one procedure was negative in 25% and 18% of cases, respectively. We conclude that the practice of same-day inpatient upper and lower endoscopy is feasible, has excellent diagnostic yield, even in the elderly, and carries no increased risks. When indicated, the practice of same-day upper and lower endoscopy should be encouraged. 相似文献
27.
28.
29.
The utility of MRI using magnetization transfer (MT) enhanced pulse sequences to diagnose hepatic cirrhosis in a rat model was investigated. Hepatic T1 was measured with and without MT off-resonance RF pulses in 17 treated and six control rats. The livers were evaluated histologically, and the hydroxyproline content quantitatively measured. We did not find a statistically significant linear correlation between the MR relaxation times and the degree of tissue injury. However, the MR measurements performed with MT were superior to those without differentiating the treated and control groups. Specifically, the T1 times were 695 ±76 ms for the treated group, versus 748 ± 61 ms in the controls; P= 0.095. The T1sat times were also lower in the treated group, with statistical significance: 367 ± 51 ms versus 421 ± 38 ms, P = 0.016. Finally, the change in the relaxation rates (the inverse of the relaxation times) with and without saturation were 1.31 ± 0.22 s?1 (treated group) versus 1.05 ± 0.12 s?1 (controls), which differed significantly, P= 0.001. 相似文献
30.
The therapeutic antibodies market to 2008. 总被引:7,自引:0,他引:7
Alex K Pavlou Mark J Belsey 《European journal of pharmaceutics and biopharmaceutics》2005,59(3):389-396
The therapeutic biologics market is currently dominated by recombinant protein products. However, many of these products are mature, and growth of the biologics market will increasingly rely on the expansion of the therapeutic monoclonal antibody sector. Successive technology waves have driven the growth of the monoclonal antibody sector, which is currently dominated by chimeric antibodies. Chimeric products, led by Remicade and Rituxan, will continue to drive market share through to 2008. However, over the forecast period, humanized and fully human monoclonal antibodies, together with technologies such as Fabs and conjugated antibodies, will play an increasingly important role, driving monoclonal antibody market growth at a forecast compound annual growth rate of 20.9%, to reach $16.7 billion by 2008. In terms of therapeutic focus, the monoclonal antibody market is heavily focused on oncology and arthritis, immune and inflammatory disorders, and products within these therapeutic areas are set to continue to be the key growth drivers over the forecast period. Underlying the growth of the market is the evolution of the monoclonal antibody company business model, set to transition towards the highly successful innovator model. 相似文献